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Receptor function is dependent on interactionwith various intracellular proteins that ensure
the localization and signaling of the receptor. While a number of approaches have been
optimized for the isolation, puriﬁcation, and proteomic characterization of receptor–protein
interaction networks (interactomes) in cells, the capture of receptor interactomes and
their dynamic properties remains a challenge. In particular, the study of interactome
components that bind to the receptor with low afﬁnity or can rapidly dissociate from
the macromolecular complex is difﬁcult. Here we describe how chemical crosslinking
(CC) can aid in the isolation and proteomic analysis of receptor–protein interactions. The
addition of CC to standard afﬁnity puriﬁcation and mass spectrometry protocols boosts
the power of protein capture within the proteomic assay and enables the identiﬁcation
of speciﬁc binding partners under various cellular and receptor states. The utility of CC in
receptor interactome studies is highlighted for the nicotinic acetylcholine receptor as well
as several other receptor types. A better understanding of receptors and their interactions
with proteins spearheads molecular biology, informs an integral part of bench medicine
which helps in drug development, drug action, and understanding the pathophysiology of
disease.
Keywords: nicotinic acetylcholine receptor, chemical crosslinking, mass spectrometry, protein–protein interaction,
signaling network, interactome
CROSSLINKING IN THE ANALYSIS OF RECEPTOR
INTERACTOMES: TO LINK OR NOT TO LINK?
To biochemically study receptor–protein interactions, one must
be able to isolate receptors and their interactomes from the lipid
plasma membrane. This process is challenging because of the
need to keep diverse protein–protein interactions intact during
the extraction and puriﬁcation of the protein complex. Addition-
ally, the structure and subcellular localization of the receptor in
the membrane dictates the chemical conditions required for pro-
tein extraction (Thomas and McNamee, 1990). Large polypeptide
membrane spanning receptors, such as ligand gated ion chan-
nels, demand strong detergent-based solubilization in order to
ensure extraction of all receptor subunits. The stringency of these
detergent conditions, however, can lead to a loss in numerous
receptor–protein associations. Receptors that are embedded in
lipid-rich and cholesterol heavy regions of the plasma membrane
(such as rafts) require unconventional solubilization methods
since these areas are resistant to detergents (Li et al., 2004; Sot et al.,
2006). The isolationof membrane bound receptors and their inter-
acting proteins is not trivial and requires extensive optimization
on a receptor-by-receptor basis (Kalipatnapu and Chattopadhyay,
2005; Sarramegn et al., 2006).
Cell-based imaging strategies for the study of receptor–protein
interactions, such as ﬂuorescence resonance energy transfer
(FRET), circumvent this problem by examining the interaction
within an intact cell (Truong and Ikura, 2001). FRET analysis,
however, only measures protein–protein interaction at relatively
large distances [∼100 Angstroms (Å)] and therefore may not be
very informative about direct protein coupling (Pollok, 1999).
Biochemical assessment of receptor–protein interaction using
standard afﬁnity puriﬁcation methods alone also suffers from
several drawbacks. First, the chemical stringency of the bio-
chemical processing steps likely compromises and/or interferes
with some receptor–protein interactions. Second, common afﬁn-
ity puriﬁcation methods such as immunoprecipitation (IP) or
pulldown assays heavily rely on the speciﬁcity of the antibody
or capturing bait and may bias toward abundant proteins and
stable protein–protein interactions. In the absence of stringent
controls, standard IP experiments can produce substantial false
positive results. Finally, current biochemical methods used to
detect protein interactions lack cellular spatial speciﬁcity; con-
sequently, when a true interaction is discovered the subcellular
localization of the interaction is unknown.
New strategies have emerged for enhancing the detection of
protein interactions. Methods such as protein fragment comple-
mentation and chemical crosslinking (CC) can stabilize transient
or labile protein interactions in vivo and in vitro (Box 1),
and therefore enable the identiﬁcation of many proteins within
the interactome (Kluger and Alagic, 2004; Morell et al., 2007).
Conventionally CC has been used in the study of extracellular
interactions of the receptor such as ligand binding (Gronemeyer
andGovindan,1986; Fanger et al., 1989; Boudreau et al., 2012; Kim
et al., 2012), studies now reveal however a utility for cell permeable
CC in the identiﬁcation of the receptor interactome (Figure 1A;
Guerrero et al., 2006; Nordman and Kabbani, 2012). In particular,
dynamic changes in protein–protein associations within receptor
www.frontiersin.org January 2014 | Volume 4 | Article 171 | 1
“fphar-04-00171” — 2014/1/6 — 15:13 — page 2 — #2
Corgiat et al. Receptor interactome crosslinking
BOX 1 | TechnicalToolbox.
• To crosslink solubilized membrane proteins in vitro with BS3, add
2 mM BS3 to the enriched receptor fraction for 2 h at 4◦C and
mix (Figure 1B).
• To crosslink proteins in vivo, add 2.5 mM DSP to cultured cells
for 2 h at 4◦C (Figure 1C). The chemical reaction with DSP can
be terminated by the addition of 50 mMTris-HCI (pH 7.5) at 4◦C.
• Clever use of DSP crosslinking enables a range of experiments
on receptor–protein interactions including an analysis of receptor
interactomes at the cell surface, inside recycled vesicles, or in
response to ligand stimulation (Figures 2A,B).
• A crosslinked receptor interactome can be puriﬁed using stan-
dard methods for immunoprecipitation and mass spectrometry
(Figure 2C).
interactomes appear better detected by CC at various stages of
the receptor preparation and puriﬁcation method (Vasilescu et al.,
2004). Interactions that are generally too weak or too transient
to be discovered in standard pulldown or IP assays alone, can
be stabilized by covalent crosslinkers during the membrane sol-
ubilization process (Bond et al., 2009; Nordman and Kabbani,
2012). The common use of stringent chemical detergents such as
radio-immunoprecipitation assay (RIPA) buffers, which interfere
with many types of protein–protein interactions, can also bene-
ﬁt from the addition of covalent crosslinkers which are generally
unperturbed by the RIPA reagent. Moreover, CC can be effectively
combined with afﬁnity puriﬁcation protocols such as the IP prior
to the mass spectrometry analysis (Vasilescu et al., 2004). To elim-
inate non-speciﬁc interactions of proteins during CC, the assay
requires optimization before the start of the study. It is also not
uncommon to run non-crosslinked samples in parallel during the
course of a study (Kim et al., 2012).
A number of crosslinkers have been used to study receptor–
protein interactions in cells (Brenner et al., 1985; Shinya et al.,
2010; Miteva et al., 2013). These compounds are characterized
by differences in their spacer arm as well as the composition
of the two amine binding groups that recognize and covalently
bind speciﬁc functional groups on target proteins (Figures 1B,C;
Sinz, 2003; Trakselis et al., 2005). Table 1 lists crosslinkers that
have been used to study receptor binding to intracellular pro-
teins. The choice of a spacer arm length, between 5 and 25 Å, is
experimentally important because it enables the identiﬁcation of
receptor–protein interactions at speciﬁc distances. A recent study
utilized agarose beads whose surface was covalently linked with a
cleavable chemical crosslinker by spacers of varied lengths to study
the interactome of the post-synaptic density isolated from the
rodent cortex (Yun-Hong et al., 2011). Experiments successfully
FIGURE 1 | Crosslinking the nAChR interactome. (A) A ﬂow chart showing
the methods for isolation, crosslinking, and proteomic analysis of nAChR
interactomes from brain tissue or neural cells. The experimental design
should take into the consideration the choice of the crosslinker as well as the
spacer arm. (B)The irreversible crosslinker BS3 is effective for crosslinking
nAChR interactomes after membrane protein solubilization with Triton-X. (C)
The membrane permeable crosslinker DSP, on the other hand, can be used to
crosslink receptors and their interacting proteins in living cells.
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Table 1 | A summary of crosslinkers used in the analysis of receptor protein interactions.
Chemical
name1
Membrane
permeable
Reversible Reactive
toward
Receptor interactome applications Spacer
arm
DSS Y N Amines Gardoni et al. (2002), Wang et al. (2002),Chu et al. (2004) 11.4
DSP Y Y; by DTT Amines Luttrell et al. (1999), Lau and Hall (2001), Quian et al. (2001), Shenoy et al. (2006) 12.0
BS3 N N Amines Aldecoa et al. (2000), Nordman and Kabbani (2012) 11.4
*MBP Y N Sulfydryls – <5
*ANB-NOS Y N Amines – 7.7
*Sulfo-SAED N Y; by DTT Amines Yun-Hong et al. (2011) 23.6
*Denotes photo-reactive linkers.
1IUPAC Names: DSS, disccinimidyl suberate; DSP, dithiobis(succinimidyl propionate; BS3, bis(sulfosuccinimidyl) suberate; MBP, 4-maleimidobenzophenone; ANB-
NOS, N-5-azido-2-nitrobenzoyloxysuccinimide; SAED, sulfosuccinididyl 2-(7-azido-4-methylcoumarin-3 -acetoadmio)-ethyl-1,3 ′-dithiopropionate.
demonstrate assemblages of proteins at various subcellular dis-
tances and compartments, including the post-synaptic density,
thus underscoring the utility of the approach in the characteriza-
tion of interactomes based on spacer arm properties. However, a
possible disadvantage of CC is that some antibodies are no longer
able to recognize their target protein after crosslinking (Boudreau
et al., 2012).
CROSSLINKING ENABLES DETECTION OF PROTEINS THAT
BIND THE RECEPTOR IN VARIOUS STATES
Interaction with trafﬁcking and chaperone proteins is impor-
tant for directing the localization and function of the receptor
(Jeanclos et al., 2001; Lin et al., 2002; Xu et al., 2006; Kabbani et al.,
2007; Nordman and Kabbani, 2012; Colombo et al., 2013). Protein
associations may also contribute to receptor conformation at the
cell surface (Giniatullin et al., 2005). While the ability to detect
receptors at the plasma membrane and in the cytosol has been
traditionally reliant on epitope tagging, live cell stain, and cell sur-
face labeling methods such as biotinylation, CC has emerged as a
complementary tool in the study of interacting proteins respon-
sible for receptor cellular trafﬁcking and localization. Numerous
examples exist in the literature, however, work on β2 adrenergic
receptor internalization has been central to understanding mech-
anisms in GPCR internalization (Lefkowitz and Shenoy, 2005).
Key ﬁndings on β2 adrenergic receptor internalization have come
from experiments using various crosslinkers to detect the associ-
ation of the receptor with the endocytosis machinery of the cells.
First, IPwas used in conjunctionwithDSP [dithiobis(succinimidyl
propionate)] crosslinking in human embryonic kidney (HEK)
293 cells to quantify changes in β2 adrenergic receptor internaliza-
tion and demonstrate that the internalized receptor was bound to
β-arrestin, which functions as an endocytic adaptor of the recep-
tor complex (Shenoy et al., 2006). In a second similar study, also
performed in HEK 293 cells that stably express the β2 adrenergic
receptor, DSP was used to show that the β2 adrenergic receptor
binds the trafﬁcking and regulatory proteins β-arrestin and c-Src
in its “desensitized” state (Luttrell et al., 1999). The study inter-
estingly demonstrates that receptor signaling is sustained even in
the absence of ligand binding. A third study on β2 adrenergic
receptor internalization employed covalent protein crosslink-
ing with DSP for the detection of transient, agonist-promoted
association of dynamin and c-Src, showing how these protein
interactions can alter the rate of receptor internalization in the cell
(Ahn, 1999).
Crosslinking has also enabled detection of changes in recep-
tor function for the angiotensin receptor (Quian et al., 2001)
and has been useful in determining interactions impacted by
post-translational modiﬁcation (Cao et al., 1999; Connolly, 1999;
Ehlers, 2000). When combined with cell surface labeling, CC
has been effective in determining changes in receptor glyco-
sylation. Differential glycosylation of cell surface human and
rat (r) calcitonin (CT) receptor-like receptors (CRLR) as a
result of interactions with accessory receptor activity-modifying
proteins (RAMPs)-1 or -2 was conﬁrmed by CC using BS3
[bis(sulfosuccinimidyl) suberate] in Drosophila S2 cells (Alde-
coa et al., 2000). In this study CC revealed receptor components
with the size of rCRLR, increased by the molecular weights of the
corresponding RAMP – suggestive of a direct association between
the receptor and the accessory protein during ligand activation.
NICOTINIC RECEPTOR INTERACTOMES DEFINED BY
CROSSLINKING
Nicotinic acetylcholine receptors (nAChRs) are a family of lig-
and gated ion channels expressed throughout the nervous system
contributing to learning, memory, and goal driven behavior
(Changeux, 2012). Recent evidence also reveals that nAChRs oper-
ate by coupling to intracellular proteins such as heterotrimeric G
proteins (Kabbani et al., 2013). Chronic nicotine exposure gives
rise to neural adaptations such as an up-regulation of speciﬁc
nAChRs through cell-delimited post-translational mechanisms
(Sallette et al., 2005; Colombo et al., 2013). These receptor mech-
anisms are a hallmark of nicotine addiction yet it is still unclear
which signaling pathways and mechanism regulate nAChR assem-
bly and trafﬁcking inside the cell. Proteomic studies, based on
yeast-two-hybrid as well as conventional IP experiments have led
to the identiﬁcation of several intracellular proteins that bind
nAChR subunits in the brain (Kabbani et al., 2007; Paulo et al.,
2009; Nordman and Kabbani, 2012; McClure-Begley et al., 2013).
Directed protein interaction screens have also enabled discovery
of proteins responsible for nAChR trafﬁcking and assembly (Lin
et al., 2002; Lansdell et al., 2005; Kabbani, 2008; Rezvani et al.,
2009).
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In the hippocampus, α7 nAChRs are expressed pre- and
post-synaptically, contributing to GABA and glutamate neuro-
transmission (Liu et al., 2006; Lozada et al., 2012). α7 receptors
are also found to mediate the growth of axons (Hancock et al.,
2008; Nordman and Kabbani, 2012) and dendrites (Campbell
et al., 2011) in the developing hippocampus. Using the membrane
impermeable and irreversible crosslinker BS3, we have deﬁned
dynamic changes in α7 interaction within solubilized membrane
fractions from differentiated PC12 cells and hippocampal neu-
rons (Figure 1B; Nordman and Kabbani, 2012). We show that
α7 receptors are directly coupled to a G protein pathway con-
sisting of Gαo, Gprin1, and GAP-43 in growing cells (Nordman
and Kabbani, 2012; Figure 1C). In these studies CC was vital to
the detection of changes in receptor interaction with signaling
molecules and heterotrimeric G proteins. The CC method was
also able to enhance the detection of small signaling molecules
such as receptor kinases in bothWestern blots and mass spectrom-
etry experiments (Hu et al., 2010; Nordman and Kabbani, 2012).
For example, using BS3 to crosslink the α7 nAChR network after
nicotine activation, we identiﬁed rapid changes to the calcium-
mediated signaling pathway of the receptor, which consisted of a
dynamic association between GAP-43 and calmodulin (CaM) in
the growing neurite (Figure 2C; Nordman and Kabbani, 2012).
In particular, activation of the α7 nAChR was found to pro-
mote a rapid association between the receptor and CaM bound
GAP-43. This interaction was rapidly reversed by ligand inac-
tivation of the α7 nAChR, showing that receptor association
with CaM bound GAP-43 was driven by nAChR channel func-
tion and calcium elevation in the cell (Nordman and Kabbani,
2012). These ﬁndings on dynamic associations of CaM and GAP-
43within theα7 nAChR interactome could not have been detected
using standard IP assays alone underscoring the utility of the
crosslinker in the study of protein interactions under physiologi-
cal conditions. In a similar study, CC with disuccinimidyl suberate
(DSS) was used in identifying dynamic changes in calcium bound
CaM kinase II and subunits of the NMDA glutamate receptor
within the post-synaptic density of hippocampal neurons (Gar-
doni et al., 2002), thus underscoring the utility of the method in
FIGURE 2 | Identifying protein interactions that mediate nAChR
trafficking, localization, and signaling. (A) Cell surface receptors can
be selectively labeled with an anti-α7 nAChR monoclonal Ab. Cell
surface labeling (at 4◦C) can be combined with DSP in order to
crosslink the receptor interactome. Alternatively, antibody labeling and
crosslinking can be used to examine changes in the receptor
interactome between internalized and cell surface nAChRs. (B) Chemical
crosslinking can be used to study the dynamics of nAChR–protein
interactions under various ligand treatment conditions. (C) Experimental
evidence on α7 nAChR interactions with GAP-43 and CaM in developing
neural cells. BS3 was used to crosslink the α7 nAChR interactome from
differentiating cells. An IP was utilized to purify the receptor, which was
visualized by SDS-PAGE. Protein identity was conﬁrmed using LC-ESI
MS and Western blot. These experiments demonstrate dynamic changes
in CaM/GAP-43 association with α7 nAChR in response to nicotine
activation (Nordman and Kabbani, 2012).
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the study of rapid calcium driven changes in protein coupling in
cells.
LOOKING AHEAD
Proteomic and yeast-two-hybrid studies on receptor interac-
tions have enabled a broad understanding on the diversity and
function of receptor–protein interactions in cells. These stud-
ies have enabled an interaction-based framework for deﬁning
the mechanisms of receptor signaling. Receptor–protein inter-
action identiﬁcation however is not sufﬁcient for understanding
how receptors operate in cells. In particular, important questions
remain on the spatial speciﬁcity and temporal aspects of recep-
tor expression and signaling in cells. For multi-subunit channel
receptors such as the glutamate AMPA receptor, the addition
of the membrane impermeable linker BS3 has proven effective
in the analysis of receptor subunit composition at the cell sur-
face (Boudreau et al., 2012). Similar approaches with the aim of
detecting protein–protein interaction in living cells are now nec-
essary. Advancement in the design and experimental utility of CC
such as photo-reactive amino acid analogs (Suchanek et al., 2005)
promises to enhance the study of receptor–protein interactions in
vivo.
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